Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Steroid use falls, but creatine use climbs rapidly

Written by | 20 May 2026

U.S. teens report far less anabolic steroid use than they did two decades ago, but creatine use has risen rapidly in recent years, according to a new University… read more.

New drug approval pathway benefits industry over patients, argues expert

Written by | 20 May 2026

A new UK drug approval pathway, designed to speed up the availability of new medicines, benefits industry over patients and the NHS, argues an expert in The BMJ today. The… read more.

Patients with Crohn’s disease maintained steroid-free remission for three years with Omvoh (mirikizumab-mrkz) – Eli Lilly

Written by | 20 May 2026

New long-term data from Eli Lilly and Company showed Omvoh (mirikizumab-mrkz) delivered durable efficacy through three years in adults with moderately to severely active Crohn’s disease. These data… read more.

AI model predicts 10-year stroke risk based on routine cardiology test

Written by | 19 May 2026

A research team co-led by investigators at Mass General Brigham and the Broad Institute of MIT and Harvard has developed and validated an artificial intelligence model, known as ECG2Stroke, that… read more.

Higher BMI is associated with more financial problems, loneliness, and stress

Written by | 19 May 2026

New research presented at this year’s European Congress on Obesity in Istanbul, Turkey (12-15 May) shows that higher body mass index (BMI) is associated with more financial problems,… read more.

MHRA (UK) approves Enflonsia (clesrovimab-cfor) for the prevention of respiratory syncytial virus (RSV) in newborns and infants – Merck

Written by | 19 May 2026

The Medicines and Healthcare products Regulatory Agency (MHRA) has  approved the medicine Enflonsia (clesrovimab-cfor) for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in newborns… read more.

More selective breeding might help flat-faced dogs to breathe easier

Written by | 18 May 2026

Breeding programs could alter heritable dog characteristics to reduce the rates of brachycephalic obstructive airway syndrome (BOAS), a breathing disorder common in dogs such as Bulldogs, French Bulldogs… read more.

Experts call on WHO to revisit its approach to airborne risk in light of hantavirus outbreak

Written by | 18 May 2026

With three people dead and 11 cases from the recent hantavirus outbreak on a cruise ship, UMD’s internationally renowned expert on airborne viruses, Dr. Don Milton,  joins public… read more.

Talzenna plus Xtandi significantly improves radiographic progression-free survival in metastatic prostate cancer – Pfizer

Written by | 18 May 2026

Pfizer Inc. announced positive topline results from the Phase III TALAPRO-3 study of Talzenna  (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with  Xtandi (enzalutamide), an… read more.

Parental support package dramatically reduced burnout in child-bearing physician trainees

Written by | 17 May 2026

Occupational burnout is a growing threat to care quality, workforce retention and physician well-being. Pregnant and postpartum physicians-in-training are especially at risk, facing stigma, limited support, and physical… read more.

The goal of a Tobacco-Free Generation will not progress without stronger EU support

Written by | 17 May 2026

A recent study shows that the rapid increase of new nicotine products and the influence of the tobacco industry are perceived to significantly hinder the European countries’ ability… read more.

Wegovy delivered substantial weight loss in women across all menopause stages, plus heart and migraine protection, shown in new data at the European Congress on Obesity – Novo Nordisk

Written by | 17 May 2026

Novo Nordisk announced data demonstrating that Wegovy (semaglutide 2.4 mg and 7.2 mg) delivers substantial and consistent weight-loss results for women with obesity across reproductive life stages, from… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.